Study of succinylated gelatin injection for elective surgery
Part of Blood & lymphatic clinical trials.
This trial tests a fluid called succinylated gelatin, given during planned surgery to help maintain blood volume. It may be an option if you are having elective surgery lasting less than 6 hours and meet specific health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You weigh between 50 and 100 kg (110 to 220 lbs) and have a body mass index (BMI) between 19 and 30.
- You are planning to have a non-emergency surgery that will take less than 6 hours.
- Your doctor expects to collect 10% to 15% of your blood volume during surgery (a procedure called acute normovolemic hemodilution).
- Your hemoglobin level is 110 g/L or higher (normal red blood cell count).
- You have no serious heart, liver, kidney, bleeding, or allergy problems, and you are not pregnant or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special fluid called succinylated gelatin (a type of colloid) given during surgery to help maintain blood volume. It is for people having planned surgery lasting less than 6 hours and who are in generally good health, without major heart, liver, or kidney problems.
This trial tests a technique called 'acute normovolemic hemodilution' during bone tumor surgery. It involves temporarily thinning your blood by removing some red blood cells and replacing them with fluid, which may reduce the need for blood transfusions.
This trial tests a technique called acute normovolemic hemodilution (ANH) during bone cancer surgery. ANH involves removing some blood before surgery and replacing it with fluids, then giving the blood back after surgery to reduce the need for donor blood transfusions.
This study tests whether a technique that thins your blood during surgery can help people having bone tumor removal. It may reduce the need for blood transfusions.
This study tests a special IV fluid called Volulyte 6% given before, during, and after major abdominal surgery. The goal is to see if it is safe and helps protect the heart and blood vessels in people who are at higher risk of heart problems.
This trial tests whether a fluid called Gelaspan (a gelatin-based IV fluid) is better for treating sepsis patients who need emergency abdominal surgery than standard crystalloid fluids. It checks if you have a belly infection and high lactate levels, and you must not have serious heart, lung, or kidney problems.
Hear when a new Acute Normovolemic Hemodilution trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.